Hikma Pharmaceuticals Share News (HIK)
HIK Share
HIK Share
HIK Share
HIK Share
HIK
HIK Share
HIK Level 2
HIK Live
HIK Broker
HIK Directors
HIK Financial
HIK
HIK Short
HIK
Last checked at -
Mon, 23rd Jun 2014 13:44
LONDON (Alliance News) - Hikma Pharmaceuticals PLC Monday said Chief Strategy and Corporate Development Officer Bassam Kanaan sold 49,476 shares at a price of GBP16.85 each Friday.
Following this transaction, Kanaan holds 454,090 shares.
Shares in the pharmaceutical company were down 0.8% at 1,674.00 pence Monday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2014 Alliance News Limited. All Rights Reserved.
(Sharecast News) - Generic drugmaker Hikma Pharmaceuticals said on Tuesday that the US District Court of Nevada had ruled that its version of Amarin Corporation's Vascepa did not infringe six patents.
Read moreDIRECTOR DEALINGS SUMMARY: Pearson And IHG Chairs Buy Amid Virus Pain
Read moreUK BROKER RATINGS SUMMARY: Citi Cuts BP And JPMorgan Downgrades Shell
Read moreUK BROKER RATINGS SUMMARY: Bernstein Upgrades easyJet And Ryanair
Read moreLONDON BRIEFING: Informa Gives No Guidance As Virus Postpones Events
Read moreUK BROKER RATINGS SUMMARY: BoFA Upgrades Burberry And Rolls-Royce
Read more
* BP, Shell lead gains as supply cut hopes boost oil prices * Miners rise; interest-rate sensitive banks, airlines decline * FTSE 100 up 1.1%, FTSE 250 falls 0.2% (Adds stock close) By Devik Jain and C Nivedita March 2 (R...
Read moreLONDON MARKET CLOSE: FTSE In Correction Territory As Virus Fears Mount
Read moreLONDON MARKET MIDDAY: Travel Stocks Bear Brunt As Virus Fears Heighten
Read moreUK WINNERS & LOSERS SUMMARY: WPP Down 15% As 2020 Outlook Disappoints
Read more(For a live blog on European stocks, type LIVE/ in an Eikon news window)* Travel and leisure, basic resources stocks worst hit* WPP leads losses on STOXX 600 after bleak forecast* Standard Chartered, AB InBev latest victims of virus damage* Hikma P...
Read more* FTSE 100 down 3.5%, FTSE 250 slides 4.1%* Both indexes briefly in correction* StanChart slips after warning on virus hit* WPP slides as Q4 disappoints* Hikma outshines on bright forecast (Writes through)By Sagarika Jaisinghani, Devik Jain and Shas...
Read more(Corrects to say U.S. sales rose 5%, not 61%, and removes reference to double-digit growth across segments in paragraph four)* 2019 core sales and core oper. profit top expectations* Sees 2020 injectables sales growth in low to mid-single digits* ...
Read more* 2019 core sales and core oper. profit top expectations* Sees 2020 injectables sales growth in low to mid-single digits* Currently does not see material impact from coronavirus outbreak (Adds details on outlook, background)Feb 27 (Reuters) - Hikm...
Read more
Last checked at